Walkner Condon Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$709K Buy
2,816
+222
+9% +$47.8K 0.08% 157
2026
Q1
$564K Sell
2,594
-625
-19% -$139K 0.07% 160
2025
Q4
$736K Buy
3,219
+129
+4% +$29.4K 0.1% 140
2025
Q3
$716K Buy
3,090
+557
+22% +$113K 0.11% 135
2025
Q2
$470K Buy
2,533
+321
+15% +$59.7K 0.09% 168
2025
Q1
$464K Buy
2,212
+160
+8% +$31.1K 0.09% 171
2024
Q4
$365K Buy
2,052
+142
+7% +$26.1K 0.07% 191
2024
Q3
$377K Buy
1,910
+216
+13% +$40.3K 0.08% 188
2024
Q2
$291K Sell
1,694
-999
-37% -$165K 0.06% 203
2024
Q1
$490K Buy
2,693
+257
+11% +$44.3K 0.1% 153
2023
Q4
$378K Buy
2,436
+182
+8% +$26.5K 0.09% 184
2023
Q3
$336K Buy
2,254
+109
+5% +$16K 0.09% 173
2023
Q2
$289K Sell
2,145
-848
-28% -$124K 0.08% 190
2023
Q1
$477K Buy
2,993
+140
+5% +$21.4K 0.13% 138
2022
Q4
$461K Buy
2,853
+344
+14% +$52.7K 0.14% 132
2022
Q3
$337K Buy
2,509
+77
+3% +$11K 0.11% 151
2022
Q2
$372K Buy
2,432
+448
+23% +$68.5K 0.12% 151
2022
Q1
$322K Buy
+1,984
New +$288K 0.09% 169

Other funds holding ABBV

Walkner Condon Financial Advisors's ABBV Position: Q2 2026 in Review

Walkner Condon Financial Advisors increased its AbbVie (ABBV) stake by 8.6% in Q2 2026, buying an estimated $47.8K and bringing the position to 2,816 shares worth $709K. The position accounts for 0.08% of the portfolio, ranked #157.

Walkner Condon Financial Advisors first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $736K in Q4 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Walkner Condon Financial Advisors held 2,816 shares of AbbVie worth $709K as of Q2 2026.
  • Walkner Condon Financial Advisors bought 222 AbbVie shares in Q2 2026, an estimated $47.8K.
  • AbbVie made up 0.08% of Walkner Condon Financial Advisors's portfolio in Q2 2026, its #157 holding.
  • Walkner Condon Financial Advisors first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • Walkner Condon Financial Advisors's AbbVie position peaked at $736K in Q4 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Walkner Condon Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.